Accès gratuit
Numéro
Réanimation
Volume 25, Numéro 3, Mai 2016
Infectieux
Page(s) 308 - 317
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1182-7
Publié en ligne 7 mars 2016
  • Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–22 [CrossRef] [PubMed] [Google Scholar]
  • Lebeaux D, Ghigo JM, Beloin C (2014) Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–43 [CrossRef] [PubMed] [Google Scholar]
  • Lebeaux D, Ghigo JM (2012) Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles? Med Sci (Paris) 28:727–39 [CrossRef] [EDP Sciences] [lavoisier] [PubMed] [Google Scholar]
  • Raisin (2013) Surveillance des infections nosocomiales en réanimation adulte. Réseau REA-Raisin, France, Résultats 2012. Institut de veille sanitaire, Saint-Maurice, 38 p [Google Scholar]
  • Grimaldi D, Llitjos JF, Pene F (2014) Post-infectious immune suppression: a new paradigm of severe infections. Med Mal Infect 44:455–63 [CrossRef] [PubMed] [Google Scholar]
  • Mourvillier B, Trouillet JL, Timsit JF, et al (2004) Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med 30:2046–52 [CrossRef] [PubMed] [Google Scholar]
  • 2012) Prévention des infections associées aux chambres à cathéter implantables pour accès veineux. Société française d'hygiène hospitalière (SF2H) [Google Scholar]
  • 2013) Bonnes pratiques et gestion des risques associés au PICC (cathéter central à insertion périphérique). Société française d'hygiène hospitalière (SF2H) [Google Scholar]
  • 2015) Révision des recommandations de bonne pratique pour la prise en charge et la prévention des infections urinaires associées aux soins (IUAS) de l’adulte. SPILF, AFU, SF2H [Google Scholar]
  • Hoiby N, Bjarnsholt T, Moser C, et al (2015) ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 21:S1–S25 [CrossRef] [PubMed] [Google Scholar]
  • Mermel LA, Allon M, Bouza E, et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45 [CrossRef] [PubMed] [Google Scholar]
  • O'Grady NP, Alexander M, Burns LA, et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–e93 [CrossRef] [PubMed] [Google Scholar]
  • (2015) Recommandations de pratique clinique — Infections ostéoarticulaires sur matériel (prothèse, implant, ostéosynthèse). SPILF, CMIT, GPIP, SFAR, SOFCOT, SF2H, SFMN, SOFMER, SFM, SFR-Rad, SFR-Rhu [Google Scholar]
  • Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2:95–108 [CrossRef] [PubMed] [Google Scholar]
  • Hoiby N (1977) Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand Suppl 262:1–96 [Google Scholar]
  • Lam J, Chan R, Lam K, Costerton JW (1980) Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 28:546–56 [PubMed] [Google Scholar]
  • Marrie TJ, Nelligan J, Costerton JW (1982) A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66:1339–41 [CrossRef] [PubMed] [Google Scholar]
  • McDougald D, Rice SA, Barraud N, Steinberg PD, Kjelleberg S (2011) Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol 10:39–50 [CrossRef] [PubMed] [Google Scholar]
  • Landini P, Antoniani D, Burgess JG, Nijland R (2010) Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 86:813–23 [CrossRef] [PubMed] [Google Scholar]
  • Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5:48–56 [CrossRef] [PubMed] [Google Scholar]
  • Lebeaux D, Ghigo JM, Beloin C (2014) Tolérance des biofilms aux antibiotiques : comprendre pour mieux traiter. J Anti-Infect 16:112–21 [CrossRef] [Google Scholar]
  • John AK, Baldoni D, Haschke M, et al (2009) Efficacy of daptomycin in implant-associated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 53:2719–24 [CrossRef] [PubMed] [Google Scholar]
  • Zimmerli W, Frei R, Widmer AF, Rajacic Z (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrobial Chemother 33:959–67 [CrossRef] [Google Scholar]
  • Zimmerli W, Moser C (2012) Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol 65:158–68 [CrossRef] [PubMed] [Google Scholar]
  • Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537–41 [CrossRef] [PubMed] [Google Scholar]
  • Authors/Task Force M, Habib G, Lancellotti P, et al (2015) 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–128 [CrossRef] [PubMed] [Google Scholar]
  • Cremieux AC, Mghir AS, Bleton R, et al (1996) Efficacy of sparfloxacin and autoradiographic diffusion pattern of [14C] Sparfloxacin in experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 40:2111–6 [PubMed] [Google Scholar]
  • Mascio CT, Alder JD, Silverman JA (2007) Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother 51:4255–60 [CrossRef] [PubMed] [Google Scholar]
  • Smith K, Perez A, Ramage G, Gemmell CG, Lang S (2009) Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin. Int J Antimicrob Agents 33:374–8 [CrossRef] [PubMed] [Google Scholar]
  • Stewart PS, Davison WM, Steenbergen JN (2009) Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 53:3505–7 [CrossRef] [PubMed] [Google Scholar]
  • Del Pozo JL, Rodil R, Aguinaga A, et al (2012) Daptomycin lock therapy for grampositive long-term catheter-related bloodstream infections. Int J Clin Pract 66:305–8 [CrossRef] [PubMed] [Google Scholar]
  • Garrigos C, Murillo O, Lora-Tamayo J, et al (2013) Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57:606–10 [CrossRef] [PubMed] [Google Scholar]
  • Corvec S, Furustrand Tafin U, Betrisey B, et al (2013) Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 57:1421–7 [CrossRef] [PubMed] [Google Scholar]
  • Ramage G, Mowat E, Jones B, et al (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35:340–55 [CrossRef] [PubMed] [Google Scholar]
  • REA-Raisin Network (2013) Surveillance of nosocomial infections in critically ill adult patients, France, available at http://www.cclinparisnord.org [Google Scholar]
  • O'Grady NP, Alexander M, Burns LA, et al (2011) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39:S1–S34 [CrossRef] [PubMed] [Google Scholar]
  • Mimoz O, Lucet JC, Kerforne T, et al (2015) Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–77 [CrossRef] [PubMed] [Google Scholar]
  • Schwebel C, Lucet JC, Vesin A, et al (2012) Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Critical Care Med 40:11–7 [CrossRef] [Google Scholar]
  • Novikov A, Lam MY, Mermel LA, et al (2012) Impact of catheter antimicrobial coating on species-specific risk of catheter colonization: a meta-analysis. Antimicrob Resist Infect Control 1:40 [CrossRef] [PubMed] [Google Scholar]
  • Souweine B, Lautrette A, Gruson D, et al (2015) Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am J Respir Crit Care Med 191:1024–32 [CrossRef] [PubMed] [Google Scholar]
  • Lebeaux D, Fernandez-Hidalgo N, Chauhan A, et al (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14:146–59 [CrossRef] [PubMed] [Google Scholar]
  • Leone M, Perrin AS, Granier I, et al (2007) A randomized trial of catheter change and short course of antibiotics for asymptomatic bacteriuria in catheterized ICU patients. Intensive Care Med 33:726–9 [CrossRef] [PubMed] [Google Scholar]
  • Tissot E, Limat S, Cornette C, Capellier G (2001) Risk factors for catheter-associated bacteriuria in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 20:260–2 [PubMed] [Google Scholar]
  • Laupland KB, Bagshaw SM, Gregson DB, et al (2005) Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 9:R60–R5 [CrossRef] [PubMed] [Google Scholar]
  • van der Kooi TI, de Boer AS, Mannien J, et al (2007) Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system. Intensive Care Med 33:271–8 [CrossRef] [PubMed] [Google Scholar]
  • Société de pathologie infectieuse de langue française (2015) Révision des recommandations de bonne pratique pour la prise en charge et la prévention des infections urinaires associées aux soins (IUAS) de l’adulte, 2015 (available at http://www.infectiologie.com/recommandaions [Google Scholar]
  • Hooton TM, Bradley SF, Cardenas DD, et al (2010) Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 50:625–63 [CrossRef] [PubMed] [Google Scholar]
  • Danin PE, Girou E, Legrand P, et al (2015) Description and microbiology of endotracheal tube biofilm in mechanically ventilated subjects. Respir Care 60:21–9 [CrossRef] [PubMed] [Google Scholar]
  • Gil-Perotin S, Ramirez P, Marti V, et al (2012) Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care 16:R93 [CrossRef] [PubMed] [Google Scholar]
  • Gorman S, Adair C, O'Neill F, et al (1993) Influence of selective decontamination of the digestive tract on microbial biofilm formation on endotracheal tubes from artificially ventilated patients. Eur J Clin Microbiol Infect Dis 12:9–17 [CrossRef] [PubMed] [Google Scholar]
  • Adair CG, Gorman SP, Byers LM, et al (2002) Eradication of endotracheal tube biofilm by nebulised gentamicin. Intensive Care Med 28:426–31 [CrossRef] [PubMed] [Google Scholar]
  • Berra L, Kolobow T, Laquerriere P, et al (2008) Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med 34:1030–7 [CrossRef] [PubMed] [Google Scholar]
  • Kollef MH, Afessa B, Anzueto A, et al (2008) Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 300:805–13 [CrossRef] [PubMed] [Google Scholar]
  • Kolobow T, Berra L, Li Bassi G, Curto F (2005) Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver. Anesthesiology 102:1063–5 [CrossRef] [PubMed] [Google Scholar]
  • Berra L, Coppadoro A, Bittner EA, et al (2012) A clinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions. Crit Care Med 40:119–24 [CrossRef] [PubMed] [Google Scholar]
  • Liu W, Zuo Z, Ma R, Zhang X (2013) Effect of mechanical cleaning of endotracheal tubes with sterile urethral catheters to reduce biofilm formation in ventilator patients. Pediatr Crit Care Med 14:e338–e43 [CrossRef] [PubMed] [Google Scholar]
  • Baddour LM, Wilson WR, Bayer AS, et al (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 132:1435–86 [CrossRef] [PubMed] [Google Scholar]
  • Baddour LM, Epstein AE, Erickson CC, et al (2010) Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121:458–77 [CrossRef] [PubMed] [Google Scholar]
  • Sohail MR, Uslan DZ, Khan AH, et al (2007) Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 49:1851–9 [CrossRef] [PubMed] [Google Scholar]
  • Athan E, Chu VH, Tattevin P, et al (2012) Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307:1727–35 [CrossRef] [PubMed] [Google Scholar]
  • Sandoe JA, Barlow G, Chambers JB, et al (2015) Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicr Chemother 70:325–59 [CrossRef] [PubMed] [Google Scholar]
  • Nielsen JC, Gerdes JC, Varma N (2015) Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J 36:2484–90 [CrossRef] [PubMed] [Google Scholar]
  • Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P (2011) Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 12:277–81 [CrossRef] [PubMed] [Google Scholar]
  • Schmidt M, Brechot N, Hariri S, et al (2012) Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 55:1633–41 [CrossRef] [PubMed] [Google Scholar]
  • O'Horo JC, Cawcutt KA, Gallo De Moraes A, et al (2016) The evidence base for prophylactic antibiotics in patients receiving extracorporeal membrane oxygenation. ASAIO J 62:6–10 [CrossRef] [PubMed] [Google Scholar]
  • ELSO general guidelines v1.3 (available at http://www.elso.org/resources/guidelines) [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.